Management of Hyponatremia
The treatment of hyponatremia must be based on the underlying cause, volume status, and symptom severity, with careful attention to correction rates to prevent osmotic demyelination syndrome. 1
Initial Assessment
- Determine the underlying cause by assessing volume status (hypovolemic, euvolemic, or hypervolemic), serum and urine osmolality, urine electrolytes, and uric acid levels 1
- Classify hyponatremia severity: mild (130-134 mmol/L), moderate (125-129 mmol/L), or severe (<125 mmol/L) 2
- Evaluate for symptoms: mild (nausea, headache, weakness) vs. severe (seizures, coma, altered mental status) 1
Treatment Based on Volume Status
Hypovolemic Hyponatremia
- Discontinue diuretics if they are the cause 3, 1
- Administer isotonic saline (0.9% NaCl) for volume repletion 1, 2
- Once volume is restored, monitor for spontaneous correction of serum sodium 1
- For severe dehydration with neurological symptoms, consider hypertonic saline with careful monitoring 3
Euvolemic Hyponatremia (e.g., SIADH)
- Implement fluid restriction (1-1.5 L/day) for moderate cases (Na 120-125 mmol/L) 3, 1
- For severe symptomatic cases, administer 3% hypertonic saline with close monitoring 1, 4
- Consider oral sodium chloride supplementation if fluid restriction alone is insufficient 1
- For refractory cases, tolvaptan may be considered (starting dose 15 mg once daily) but must be initiated in hospital setting 5
Hypervolemic Hyponatremia (e.g., cirrhosis, heart failure)
- Implement fluid restriction to 1-1.5 L/day for serum sodium <125 mmol/L 3, 1
- Address the underlying cause (e.g., heart failure, cirrhosis management) 2
- Consider albumin infusion for patients with cirrhosis 3
- Avoid hypertonic saline unless life-threatening symptoms are present, as it may worsen edema and ascites 3
Correction Rate Guidelines
- For severe symptomatic hyponatremia: Correct by 4-6 mmol/L in the first 6 hours or until symptoms improve 1, 6
- Maximum correction rate: Do not exceed 8 mmol/L in 24 hours to prevent osmotic demyelination syndrome 1, 5
- For patients with liver disease or malnutrition: Use even more conservative correction rates (4-6 mmol/L per day) due to higher risk of osmotic demyelination 1, 3
- Monitor serum sodium frequently: Every 2-4 hours during active correction 1
Special Considerations
Vaptans (Vasopressin Receptor Antagonists)
- Tolvaptan is FDA-approved for clinically significant hypervolemic and euvolemic hyponatremia 5
- Must be initiated in a hospital setting with close monitoring of serum sodium 5
- Starting dose is 15 mg once daily, which can be increased to 30 mg after 24 hours if needed 5
- Do not administer for more than 30 days due to risk of liver injury 5
- Avoid fluid restriction during the first 24 hours of tolvaptan therapy 5
- Contraindicated in hypovolemic hyponatremia and in patients unable to sense or respond to thirst 5
Cerebral Salt Wasting (CSW)
- Unlike SIADH, CSW requires volume and sodium replacement rather than fluid restriction 1
- Treatment focuses on isotonic or hypertonic saline and may include fludrocortisone 1
Common Pitfalls to Avoid
- Overly rapid correction (>8 mmol/L/24 hours) leading to osmotic demyelination syndrome 1, 5
- Using fluid restriction in CSW, which can worsen outcomes 1
- Inadequate monitoring during active correction 1
- Using hypertonic saline in hypervolemic hyponatremia without life-threatening symptoms 1
- Failing to recognize and treat the underlying cause 1
- Administering hypotonic fluids to patients with SIADH, which can worsen hyponatremia 1
Practical Approach to Severe Symptomatic Hyponatremia
- Administer 3% hypertonic saline (100 mL bolus over 10-15 minutes) 4, 6
- Monitor serum sodium every 1-2 hours until symptoms improve 1
- Aim for 4-6 mmol/L increase in the first 6 hours or until severe symptoms resolve 1
- Once symptoms improve, slow the correction rate to stay within the 8 mmol/L per 24-hour limit 1, 5
- Calculate sodium deficit to guide therapy: Desired increase in Na (mEq/L) × (0.5 × ideal body weight in kg) 1
By following these guidelines and carefully monitoring correction rates, hyponatremia can be safely and effectively managed while minimizing the risk of complications.